2090 related articles for article (PubMed ID: 18236022)
41. Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity.
Muda M; He C; Martini PG; Ferraro T; Layfield S; Taylor D; Chevrier C; Schweickhardt R; Kelton C; Ryan PL; Bathgate RA
Mol Hum Reprod; 2005 Aug; 11(8):591-600. PubMed ID: 16051677
[TBL] [Abstract][Full Text] [Related]
42. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
[TBL] [Abstract][Full Text] [Related]
43. Relaxin-a pleiotropic hormone and its emerging role for experimental and clinical therapeutics.
Dschietzig T; Bartsch C; Baumann G; Stangl K
Pharmacol Ther; 2006 Oct; 112(1):38-56. PubMed ID: 16647137
[TBL] [Abstract][Full Text] [Related]
44. LGR7-truncate is a splice variant of the relaxin receptor LGR7 and is a relaxin antagonist in vitro.
Scott DJ; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():22-6. PubMed ID: 15956683
[TBL] [Abstract][Full Text] [Related]
45. Identification of binding sites with differing affinity and potency for relaxin analogues on LGR7 and LGR8 receptors.
Halls ML; Bathgate RA; Sudo S; Kumagai J; Bond CP; Summers RJ
Ann N Y Acad Sci; 2005 May; 1041():17-21. PubMed ID: 15956682
[TBL] [Abstract][Full Text] [Related]
46. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.
Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD
Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442
[TBL] [Abstract][Full Text] [Related]
47. Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo.
Bathgate RA; Lin F; Hanson NF; Otvos L; Guidolin A; Giannakis C; Bastiras S; Layfield SL; Ferraro T; Ma S; Zhao C; Gundlach AL; Samuel CS; Tregear GW; Wade JD
Biochemistry; 2006 Jan; 45(3):1043-53. PubMed ID: 16411781
[TBL] [Abstract][Full Text] [Related]
48. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
49. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
[TBL] [Abstract][Full Text] [Related]
50. H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3).
van der Westhuizen ET; Christopoulos A; Sexton PM; Wade JD; Summers RJ
Mol Pharmacol; 2010 May; 77(5):759-72. PubMed ID: 20159943
[TBL] [Abstract][Full Text] [Related]
51. Relaxin family peptides and receptors in mammalian brain.
Gundlach AL; Ma S; Sang Q; Shen PJ; Piccenna L; Sedaghat K; Smith CM; Bathgate RA; Lawrence AJ; Tregear GW; Wade JD; Finkelstein DI; Bonaventure P; Liu C; Lovenberg TW; Sutton SW
Ann N Y Acad Sci; 2009 Apr; 1160():226-35. PubMed ID: 19416194
[TBL] [Abstract][Full Text] [Related]
52. Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus.
Ganella DE; Callander GE; Ma S; Bye CR; Gundlach AL; Bathgate RA
Gene Ther; 2013 Jul; 20(7):703-16. PubMed ID: 23135160
[TBL] [Abstract][Full Text] [Related]
53. Development of a selective agonist for relaxin family peptide receptor 3.
Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
[TBL] [Abstract][Full Text] [Related]
54. Characterization of the mouse and rat relaxin receptors.
Scott DJ; Layfield S; Riesewijk A; Morita H; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():8-12. PubMed ID: 15956680
[TBL] [Abstract][Full Text] [Related]
55. Identification of INSL5, a new member of the insulin superfamily.
Conklin D; Lofton-Day CE; Haldeman BA; Ching A; Whitmore TE; Lok S; Jaspers S
Genomics; 1999 Aug; 60(1):50-6. PubMed ID: 10458910
[TBL] [Abstract][Full Text] [Related]
56. Improved chemical synthesis and demonstration of the relaxin receptor binding affinity and biological activity of mouse relaxin.
Samuel CS; Lin F; Hossain MA; Zhao C; Ferraro T; Bathgate RA; Tregear GW; Wade JD
Biochemistry; 2007 May; 46(18):5374-81. PubMed ID: 17425335
[TBL] [Abstract][Full Text] [Related]
57. Synthetic human insulin 4 does not activate the G-protein-coupled receptors LGR7 or LGR8.
Lin F; Otvos L; Kumagai J; Tregear GW; Bathgate RA; Wade JD
J Pept Sci; 2004 May; 10(5):257-64. PubMed ID: 15160837
[TBL] [Abstract][Full Text] [Related]
58. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4.
Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393
[TBL] [Abstract][Full Text] [Related]
59. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
[TBL] [Abstract][Full Text] [Related]
60. The A-chain of human relaxin family peptides has distinct roles in the binding and activation of the different relaxin family peptide receptors.
Hossain MA; Rosengren KJ; Haugaard-Jönsson LM; Zhang S; Layfield S; Ferraro T; Daly NL; Tregear GW; Wade JD; Bathgate RA
J Biol Chem; 2008 Jun; 283(25):17287-97. PubMed ID: 18434306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
